비교리스트

 카트 문의
시장보고서
상품코드
1373906

세계의 국소 마취제 시장 : 약제 유형별, 용도별, 유통 채널별, 국가별, 지역별-산업 분석, 시장 규모, 시장 점유율 및 예측(2023-2030년)

Local Anesthesia Drugs Market, By Drug Type, By Application, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 334 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

국소 마취제(Local Anesthesia Drugs) 시장 규모는 2022년 27억 8,030만 달러에서 2023년부터 2030년까지 CAGR 6.6%로 추이하며 성장 할 것으로 예상됩니다.

국소 마취제 시장-시장 역학

만성 질환 증가가 시장 수요에 박차를 가합니다.

당뇨병이나 암 등 만성 질환 증가, 이러한 질환에 의한 입원비의 상승이, 예측 기간중의 국소 마취 시장 점유율 성장을 견인하고 있습니다. 암 환자는 수술, 마취, 진통제, 입원이 필요합니다. 오피오이드와 국소 마취제는 진통 치료를 위해 처방됩니다. 또한 세계에서 수행되는 수술 건수 증가는 사고, 치과 치료, 호흡기 질환, 신경 질환, 암, 심혈관 질환, 위장 질환, 척추 질환, 정형외과 질환 등 만성 질환이되기 쉽다. 나이와 관련된 문제로 인해 발생합니다. 따라서 이러한 요인은 국소 마취제 수요를 촉진할 가능성이 높습니다. 그러나, 의료 종사자와 환자에 의한 국소 마취의 사용을 필요로 하지 않는 비침습적 수술의 사용은 국소 마취제 시장의 수익 성장을 방해할 것으로 예상됩니다. 또한 국소 마취제는 의사뿐만 아니라 환자에게도 많은 이점을 제공합니다. 예를 들어, 국소 마취제를 주사하기 위해 마취과 의사는 필요하지 않습니다. 의사와 외과 의사는 수술을 시작하기 전에 국소 마취제를 제공할 수 있습니다. 국소 마취제와 관련된 부작용은 드물며 매우 가볍습니다. 이에 따라 삼키는 폐렴의 위험이 적고 수술이 지연되지 않고 환자는 조기에 귀가할 수 있습니다. 이러한 요인은 예측 기간 동안 국소 마취제 부문에 긍정적인 영향을 미칠 것으로 예측됩니다.

국소 마취제 시장-주요 통찰

우리의 연구 분석가가 점유율한 분석에 따르면 세계 국소 마취제 시장은 예측 기간(2023-2030년)에 약 6.6%의 CAGR로 매년 성장할 것으로 예측됩니다.

국소 마취제 산업은 국소 마취제의 많은 장점과 만성 질환의 이환율이 증가함에 따라 상당한 속도로 성장할 것으로 예상됩니다.

약물 유형별로 리도카인은 2022년에 가장 큰 시장 점유율을 기록했습니다.

용도별로 주사제는 2022년의 주요 유형이었습니다.

전신 마취에 사용되는 약물은 치료 중에 환자를 잠들기 때문에 국소 마취제와 다릅니다.

국소 마취제 시장-세분화 분석 :

세계의 국소 마취제 시장은 약물 유형, 용도, 유통 채널, 지역에 따라 구분됩니다.

약물 유형에 따라 벤조카인, 부피바카인, 리도카인, 로피바카인, 프리로카인, 클로로프로카인 등 6가지로 분류됩니다. 리도카인 부문이 가장 높은 시장 점유율을 차지합니다. 리도카인에 의한 국소 마취는 수술 및 주사 전에 피부에 마비를 일으키는 데 널리 사용됩니다. 특정 의료 절차 전에 리도카 잉크림은 마비와 감각의 상실을 유발하는 데 사용됩니다. 이는 통증의 감각을 최소화하는 신체의 신경 신호 전달을 차단함으로써 효율적으로 작동합니다.

시장은 용도에 따라 표면 마취제와 주사제의 두 가지로 분류됩니다. 예측 기간 동안 가장 큰 시장 점유율을 차지하는 것은 주사제 일 것입니다. 주사용 국소 마취제는 오랫동안 사용되어 왔으며 상당히 흔합니다. 또한, 비용 효과적이고 의료 치료 중 마비를 위해 필요합니다. 국소 마취제는 뇌와 통증의 발생원 사이를 차단하는 역할을 하며, 일시적으로 신경 활동을 억제하고 뇌에 신호를 전달함으로써 환자에게 무감각감을 줍니다.

국소 마취제 시장-지리적 통찰

지역별 분석에 따르면 시장은 북미, 아시아 태평양, 유럽, 중동, 아프리카, 중남미로 분류됩니다. 북미 시장은 인프라 정비와 기술 진보에 따른 건강 관리 투자 증가로 우세할 것으로 예측됩니다. 또, 공적기관과 민간기관이 전략적으로 협력·제휴해, 치료 결과의 향상에 노력하고 있습니다. 또한 유럽은 수술 후 완화 수요, 일반 인구 증가, 만성 질환 증가로 2위 시장이 될 것으로 추정됩니다. 또한 유럽은 혁신적인 제품을 도입하여 주요 기업을 늘리기 위해 장비 및 기구에 대한 지원 상환 제도를 가지고 있기 때문에 시장은 수익을 올릴 가능성이 높습니다.

국소 마취제 시장-경쟁 구도 :

헬스케어에 대한 지출 증가, 신규 파이프라인 제품 출시 증가, R&D 활동 활성화, 주요 기업들의 투자 급증이 시장 개척을 뒷받침합니다. 또한, 마취약 사업에서는 합병의 형태로 집중이 일반적으로 되고 있습니다. 이는 주로 마취제 제조회사를 시작하는 데 필요한 많은 양의 지적재산 투자와 R&D 투자 때문입니다. M&A는 이런 측면에서 비용 효율적이고 시간 효율적인 접근법으로 간주됩니다. 예를 들어, 2021년 3월, Pacira BioSciences, Inc.는 미국 식품의약국(FDA)이 EXPAREL의 첨부 문서를 수술 후 국소 진통을 목적으로 한 단일 용량 침윤의 6세 이상의 환자에게 사용 를 포함하도록 확대할 것을 요구하는 추가 신약 승인 신청(sNDA) 제출을 승인했다고 발표했습니다. EXPAREL은 이번 승인에 따라 FDA가 승인한 6세 이하의 소아 환자를 대상으로 한 최초의 유일한 장시간 작용형 국소 진통제가 됩니다.

목차

제1장 국소 마취제 시장 개요

  • 조사 범위
  • 시장 추정 연도

제2장 주요 요약

  • 시장 분석
  • 경쟁 인사이트

제3장 국소 마취제의 주요 시장 동향

  • 시장 성장 촉진 요인
  • 시장 성장 억제 요인
  • 시장 기회
  • 향후 시장 동향

제4장 국소 마취제 산업의 조사

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 맵핑
  • 규제 프레임워크 분석

제5장 국소 마취제 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 후의 영향 분석

제6장 국소 마취제 시장 상황

  • 국소 마취제 시장 점유율 분석(2022년)
  • 주요 제조업체별 분석 데이터
    • 기존 기업 분석
    • 신흥 기업 분석

제7장 국소 마취제 시장-약제 유형별

  • 개요
    • 약제 유형별 부문 점유율 분석
    • 벤조카인
    • 부피바카인
    • 리도카인
    • 로피바카인
    • 프리로카인
    • 클로로프로카인
    • 기타

제8장 국소 마취제 시장-용도별

  • 개요
    • 용도별 부문 점유율 분석
    • 표면 마취제
    • 주사 가능

제9장 국소 마취제 시장-유통 채널별

  • 개요
    • 판매 채널별 부문 점유율 분석
    • 약국 점포
    • 병원 약국
    • 기타

제10장 국소 마취제 시장-지역

  • 소개
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아 태평양(APAC)
    • 개요
    • 아시아 태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 남미
    • 개요
    • 남미의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석-국소 마취제 산업

  • 경쟁 대시보드
  • 기업 개요
    • Pacira Pharmaceuticals, Inc.
    • Novartis AG
    • Aspen Pharmacare
    • Advanced Pharma, Inc.
    • Sagent Pharmaceuticals
    • Baxter International, Inc.
    • Hikma Pharmaceuticals plc
    • Teva Pharmaceutical Industries Ltd.
    • Akorn, Inc.
    • GSK plc.
    • Fresenius Kabi
    • Mylan NV
    • AstraZeneca plc

제12장 애널리스트의 전방위 전망

LYJ 23.11.13

REPORT HIGHLIGHT

Local anesthesia drugs market size was valued at USD 2,780.3 Million in 2022, expanding at a CAGR of 6.6% from 2023 to 2030.

Local anesthesia is a loss of sensation in a specific area or place of the body. Drugs that include local anesthetics are used to treat uncomfortable situations, relieve pain while performing minor or large surgeries, and reduce pain post-surgery. Additionally, some drugs act as local anesthetics at greater doses. Moreover, a local anesthetic can be directly administered to the affected area or it can be absorbed through the skin. The doctor might employ a different anesthetic that lasts 4 to 6 hours when a vast area requires to be numbed or medications may not work well enough.

Local Anesthesia Drugs Market- Market Dynamics

The rising prevalence of chronic diseases is fueling the market demand

Increasing cases of chronic diseases, such as diabetes and cancer as well as high hospitalization costs because of these diseases across the globe, is accounted to drive the local anesthesia market share growth during the forecast period. Patients suffering from cancer need surgery, anesthetic, pain medication, and hospitalization. Opioids and local anesthetics are often prescribed to treat analgesia. Additionally, rising incidences of surgeries performed around the world can be attributed to accidents, dental treatments, and age-related issue, which is more prone to chronic diseases including respiratory ailments, neurological disorders, cancer, cardiovascular disorders, gastro, spinal difficulties, and orthopedic. Thus, such factors are likely to propel the demand for local anesthesia drugs. However, the use of non-invasive surgeries that do not need the use of local anesthesia by healthcare professionals or patients is expected to hinder local anesthesia drugs market revenue growth. Furthermore, local anesthesia drugs provide numerous benefits to the doctor as well as the patient, for instance, for injecting local anesthesia drugs, anesthesiologist is not required. The doctors and surgeons can offer local anesthesia drugs before starting the operation of the procedure. The side effects related to local anesthesia drugs are uncommon and very mild. In line with this, due to these factors, there is less risk of aspiration pneumonia, no delay in the procedure, and patients can go home early. These factors are projected to have a positive impact on the local anesthesia drugs sector over the projection timeframe.

Local Anesthesia Drugs Market- Key Insights

As per the analysis shared by our research analyst, the global local anesthesia drugs market is estimated to grow annually at a CAGR of around 6.6% over the forecast period (2023-2030)

The local anesthesia drugs industry is projected to grow at a significant rate due to the numerous benefits of local anesthesia drugs and rising incidence of chronic disease

Based on drug type segmentation, lidocaine was predicted to show maximum market share in the year 2022

Based on application segmentation, injectable was the leading type in 2022

Drugs used for general anesthesia lay the patient to sleep during the procedure and, therefore differ from local anesthetics.

Local Anesthesia Drugs Market- Segmentation Analysis:

The global local anesthesia drugs market is segmented on the basis of drug type, application, distribution channel, and region.

The market is divided into six categories based on drug type: benzocaine, bupivacaine, lidocaine, ropivacaine, prilocaine, chloroprocaine, and others. The lidocaine segment is attributed to dominate the highest market share. Local anesthesia is widely used by lidocaine to produce numbness on the skin before surgical procedures or injections. Before specific medical procedures lidocaine cream is used for inducing numbness or loss of feeling. It works efficiently by blocking the transmission of nerve signals in the body that minimize the pain sensation.

The market is divided into two categories based on applications: surface anesthetic and injectable. The injectable is likely to possess the largest market share during the forecast period. The injectable local anesthesia drugs have been in use for a long time and are quite common. Additionally, they are cost-effective and will be required for numbness during medical procedures. They act as a roadblock between the brain and the source of pain that temporarily inhibits the nerve's activity to transfer the signals to the brain thereby creating a feeling of numbness in patients.

Local Anesthesia Drugs Market- Geographical Insights

As per the geographical analysis, the market is classified into North America, Asia Pacific, Europe, Middle East & Africa, and Central & South America. The market for North America is projected to predominate due to increasing healthcare investments with improved infrastructure and technological advancements. Additionally, public and private agencies collaborate and partner strategically to improve outcomes in the treatment. Moreover, Europe is estimated to be the second-largest market owing to the demand for post-surgery relief, rising generic population, and increasing chronic diseases. The European region also has supportive reimbursement facilities for devices and instruments which will lead to an increasing key player by introducing innovative products and thus the market is more likely to generate revenue.

Local Anesthesia Drugs Market- Competitive Landscape:

The increasing spending on healthcare, increasing new pipeline product launches, increasing research & development activities, and burgeoning investments from key players will boost the market development. Moreover, growing concentration in the form of mergers is becoming more common in the anesthetics business. This is mostly due to the significant intellectual property investments and research & development investment needed to start anesthetic pharmaceutical manufacturing companies. Mergers and acquisitions are seen as cost-effective and time-efficient approaches in this aspect. For instance, in March 2021, Pacira BioSciences, Inc. announced the U.S. Food and Drug Administration (FDA) has approved the submission of its supplemental new drug application (sNDA) seeking expansion of the EXPAREL label to involve use in patients 6 years of age and older for single-dose infiltration to develop postsurgical local analgesia. EXPAREL is the first and only FDA-approved long-acting local analgesic for the pediatric population as young as age six, with this approval.

Recent Developments:

For instance, in June 2023, Hikma Pharmaceuticals PLC launched Dobutamine Injection, USP, in a 250mg/20mL vial in the US. Hikma's extensive US portfolio of sterile injectable medicines now exceeds 150 products spanning a variety of therapeutic areas and dosage forms, with this launch.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LOCAL ANESTHESIA DRUGS MARKET KEY PLAYERS

  • Pacira Pharmaceuticals, Inc.
  • Novartis AG
  • Aspen Pharmacare
  • Advanced Pharma, Inc.
  • Sagent Pharmaceuticals
  • Baxter International, Inc.
  • Hikma Pharmaceuticals plc
  • Teva Pharmaceutical Industries Ltd.
  • Akorn, Inc.
  • GSK plc.
  • Fresenius Kabi
  • Mylan N.V.
  • AstraZeneca plc

GLOBAL LOCAL ANESTHESIA DRUGS MARKET, BY DRUG TYPE

  • Benzocaine
  • Bupivacaine
  • Lidocaine
  • Ropivacaine
  • Prilocaine
  • Chloroprocaine
  • Others

GLOBAL LOCAL ANESTHESIA DRUGS MARKET, BY APPLICATION

  • Surface Anesthetic
  • Injectable

GLOBAL LOCAL ANESTHESIA DRUGS MARKET, BY DISTRIBUTION CHANNEL

  • Pharmacy Stores
  • Hospital Pharmacies
  • Others

GLOBAL LOCAL ANESTHESIA DRUGS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Local Anesthesia Drugs Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Local Anesthesia Drugs Market Snippet by Drugs Type
    • 2.1.2. Local Anesthesia Drugs Market Snippet by Application
    • 2.1.3. Local Anesthesia Drugs Market Snippet by Distribution Channel
    • 2.1.4. Local Anesthesia Drugs Market Snippet by Country
    • 2.1.5. Local Anesthesia Drugs Market Snippet by Region
  • 2.2. Competitive Insights

3. Local Anesthesia Drugs Key Market Trends

  • 3.1. Local Anesthesia Drugs Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Local Anesthesia Drugs Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Local Anesthesia Drugs Market Opportunities
  • 3.4. Local Anesthesia Drugs Market Future Trends

4. Local Anesthesia Drugs Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Local Anesthesia Drugs Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Local Anesthesia Drugs Market Landscape

  • 6.1. Local Anesthesia Drugs Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Local Anesthesia Drugs Market - By Drugs Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drugs Type, 2022&2030 (%)
    • 7.1.2. Benzocaine
    • 7.1.3. Bupivacaine
    • 7.1.4. Lidocaine
    • 7.1.5. Ropivacaine
    • 7.1.6. Prilocaine
    • 7.1.7. Chloroprocaine
    • 7.1.8. Others

8. Local Anesthesia Drugs Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022&2030 (%)
    • 8.1.2. Surface Anesthetic
    • 8.1.3. Injectable

9. Local Anesthesia Drugs Market - By Distribution Channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution Channel, 2022&2030 (%)
    • 9.1.2. Pharmacy Stores
    • 9.1.3. Hospital Pharmacies
    • 9.1.4. Others

10. Local Anesthesia Drugs Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Local Anesthesia Drugs Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Local Anesthesia Drugs Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Local Anesthesia Drugs Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Local Anesthesia Drugs Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Local Anesthesia Drugs Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Drugs Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Local Anesthesia Drugs Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Pacira Pharmaceuticals, Inc.
    • 11.2.2. Novartis AG
    • 11.2.3. Aspen Pharmacare
    • 11.2.4. Advanced Pharma, Inc.
    • 11.2.5. Sagent Pharmaceuticals
    • 11.2.6. Baxter International, Inc.
    • 11.2.7. Hikma Pharmaceuticals plc
    • 11.2.8. Teva Pharmaceutical Industries Ltd.
    • 11.2.9. Akorn, Inc.
    • 11.2.10. GSK plc.
    • 11.2.11. Fresenius Kabi
    • 11.2.12. Mylan N.V.
    • 11.2.13. AstraZeneca plc

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제